KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline

Hypertension is a modifiable risk factor for cardiovascular morbidity and mortality and reduction of elevated blood pressure (BP) remains an important intervention for slowing kidney disease progression. Over the past decade, the most appropriate BP target for initiation and titration of BP-lowering...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Kidney Dis
Main Authors: Kramer, Holly J., Townsend, Raymond R., Griffin, Karen, Flynn, Joseph T., Weiner, Daniel E., Rocco, Michael V., Choi, Michael J., Weir, Matthew R., Chang, Tara I., Agarwal, Rajiv, Beddhu, Srinivasan
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6740329/
https://ncbi.nlm.nih.gov/pubmed/30905361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2019.01.007
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki